M&A Deal Summary |
|
|---|---|
| Date | 2020-09-25 |
| Target | Sundia MediTech |
| Sector | Life Science |
| Buyer(s) | BioDuro-Sundia |
| Deal Type | Add-on Acquisition |
SEARCH BY
BioDuro-Sundia is a global life science contract research and development organization that provides biopharmaceutical clients and partners with comprehensive, fully integrated drug discovery services spanning target identification to IND filing, through to GMP manufacture of drug substance for clinical trials. BioDuro-Sundia was founded in 1996 and is based in Irvine, California.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| Country: China M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-03-05 |
Molecular Response
San Diego, California, United States Molecular Response LLC is a provider of biobank facility & utilizes intelligently-designed tumor models to discover novel oncology drugs. Molecular Response reduce risk and cost of targeted therapeutics through key risk-shared partnerships by use of fully characterized efficacy models and clinically relevant molecular response marker data to create a clinically predictive knowledge base while fully integrated into existing pharmaceutical development processes and programs. Molecular Response was founded in 2010 and is based in San Diego, California. |
Buy | - |
